Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

FDA clears AI platform for PET imaging enhancement and quantification

17 September 2026 · By · Wire by Fusion42

Published

17 September 2026

Topic

opportunities

◆ Sectors

Health

◆ Geography

United States

◆ Source

Read at radiologybusiness.com →

◆ Verified

Fusion42 · 17 September 2026 · Fusion42 review

Microstructure Imaging Inc. received FDA 510(k) clearance for MICSI-PET, an AI-enabled software that enhances neurological PET images using MRI guidance, supporting improved visualization and automated quantification for neurodegenerative disease evaluation.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

FDA clearance of this AI platform opens the US neuroimaging market to software that integrates without new hardware, letting you add advanced image enhancement and quantification to existing PET setups immediately.

◆ Coverage

1 source · 17 Sep 2026

◆ Related on Wire

◆ Topics

Healthfda-clearanceai-medical-imagingpet-imagingneurologyquantification